Clinical Research Development Center, Shahid Beheshti Hospital, Qom University of Medical Sciences, Qom, Iran.
Cell therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Osteoporos Int. 2020 Oct;31(10):1975-1984. doi: 10.1007/s00198-020-05455-4. Epub 2020 May 21.
Based on the clinical, BMD, and TBS data of 2380 participants aged ≥ 60 which was gathered during the BEH program, stage II, we showed that MetS was positively associated with BMD, while a negative or no association was observed between MetS and TBS depending on the sex and the adjustment model.
The results of previous reports in regard to the effect of metabolic syndrome (MetS) on bone health are not conclusive. This study aimed to evaluate the association between MetS with bone mineral density (BMD) and trabecular bone score (TBS) as an indicator of bone quantity and quality, respectively.
Using a cross-sectional design, this study was carried out based on the data collected during the BEH Program, stage II. MetS was defined according to NCEP-ATP III criteria. BMD (at the lumbar spine and the hip) and lumbar spine TBS were assessed by dual-energy X-ray absorptiometry device.
The data of 2380 participants (women = 1228, men = 1152) aged ≥ 60 were analyzed. In the fully adjusted regression models (including BMI), significant associations between MetS and mean BMD were observed across all locations in men (P values ≤ 0.001) and in the lumbar spine in women (P value = 0.003). In addition, the prevalence of osteoporosis (based on BMD) was significantly lower in those with MetS than those without MetS in both sexes, even after full adjustments (women, OR = 0.707, P value = 0.013; men, OR = 0.563, P value = 0.001). In contrast, in age-adjusted regression analyses, the prevalence of degraded bone microarchitecture (TBS ≤ 1.2) was significantly increased in those with MetS than those without, irrespective of the participants' sex (P values < 0.05). The mean TBS was also negatively associated with MetS in women (β = - 0.075, P value = 0.007) but not in men (β = - 0.052, P value = 0.077), in age-adjusted regression models. However, after including BMI in the adjusted models, all significant associations between TBS values and MetS disappeared.
It seems that a positive association exists between MetS and BMD, while MetS is either not associated or negatively correlated with bone quality as measured by TBS.
评估代谢综合征(MetS)与骨密度(BMD)和骨小梁评分(TBS)之间的关系,分别作为骨量和骨质量的指标。
使用横断面设计,基于 BEH 项目第二阶段的数据进行研究。MetS 根据 NCEP-ATP III 标准定义。使用双能 X 射线吸收仪评估腰椎和髋部 BMD 以及腰椎 TBS。
共分析了 2380 名年龄≥60 岁的参与者(女性 1228 人,男性 1152 人)的数据。在包括 BMI 的全调整回归模型中,男性所有部位(P 值均≤0.001)和女性腰椎(P 值=0.003)的 MetS 与平均 BMD 之间存在显著关联。此外,即使在充分调整后,两性中患有 MetS 的患者骨质疏松症(基于 BMD)的患病率也明显低于无 MetS 的患者(女性,OR=0.707,P 值=0.013;男性,OR=0.563,P 值=0.001)。相反,在年龄调整的回归分析中,无论参与者的性别如何,患有 MetS 的患者的骨微结构恶化(TBS≤1.2)的患病率均显著增加(P 值均<0.05)。在年龄调整的回归模型中,女性的 TBS 平均值也与 MetS 呈负相关(β=-0.075,P 值=0.007),但男性则没有(β=-0.052,P 值=0.077)。然而,在将 BMI 纳入调整模型后,TBS 值与 MetS 之间的所有显著关联均消失。
似乎 MetS 与 BMD 之间存在正相关,而 MetS 与 TBS 测量的骨质量之间没有关联或呈负相关。